Interferon-α combined with radiotherapy in the treatment of unresectable melanoma

被引：3
|
作者：
Nguyen, NP
Sallah, S
Childress, C
Salehpour, MR
Karlsson, U
机构：
[1] SW Texas State Univ, VA N Texas Hlth Care Syst, Dept Radiat Oncol, Dallas, TX 75216 USA
[2] Univ Tennessee, Div Hematol Oncol, Memphis, TN 38163 USA
[3] Leo Jenkins Canc Ctr, Dept Radiat Oncol, Greenville, NC USA
来源：
CANCER INVESTIGATION | 2001年 / 19卷 / 03期
关键词：
D O I：
10.1081/CNV-100102553
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A case of recurrent and twice resected sinonasal melanoma is presented. The large recurrent tumor was found to regress by a concurrent combination of 6660 cc!: photon radiation and subcutaneous interferon-alpha injections given for a period of 8 weeks. Possible mechanisms of potentiation between interferon and radiation are discussed The unexpected result in this case report raises interesting questions about this treatment combination.
引用
收藏
页码：261 / 265
页数：5
相关论文
共 50 条
  • [41] Interferon-α Treatment in Systemic Mastocytosis
    Bjerrum, Ole Weis
    CURRENT DRUG TARGETS, 2011, 12 (03) : 433 - 436
  • [42] Interferon-β for treatment of rheumatoid arthritis?
    Judith van Holten
    Christine Plater-Zyberk
    Paul P Tak
    Arthritis Research & Therapy, 4
  • [43] High dose interferon-α-2b adjuvant treatment for melanoma:: The UK experience
    Katerinaki, E
    Kularatne, B
    Hambly, R
    Turner, L
    Hancock, BW
    Lorigan, P
    BRITISH JOURNAL OF CANCER, 2003, 88 : S66 - S66
  • [44] Autoimmune response as a side effect of treatment with interferon-α in melanoma: does this have prognostic implications?
    Palacios-Alvarez, Irene
    Roman-Curto, Concepcion
    Mir-Bonafe, Jose M.
    Canueto, Javier
    Usero-Barcena, Teresa
    Fernandez-Lopez, Emilia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (03) : E91 - E93
  • [45] The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-α treatment
    Guillot, B
    Portalès, P
    Du Thanh, A
    Merlet, S
    Dereure, O
    Clot, J
    Corbeau, P
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (04) : 690 - 696
  • [46] Combined treatment with subcutaneous interferon-α, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis
    Aydin, ÖF
    Senbil, N
    Kuyucu, N
    Gürer, Y
    JOURNAL OF CHILD NEUROLOGY, 2003, 18 (02) : 104 - 108
  • [47] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    BIODRUGS, 2000, 13 (04) : 299 - 304
  • [48] Effect of natural interferon-β on the growth of melanoma cell lines
    Nagatani, T
    Okazawa, H
    Kambara, T
    Satoh, K
    Nishiyama, T
    Tokura, H
    Yamada, R
    Nakajima, H
    MELANOMA RESEARCH, 1998, 8 (04) : 295 - 299
  • [49] Primary treatment of unresectable keloids with radiotherapy
    Malaker, K
    Vijayraghayan, K
    Hodson, I
    Al Yafi, T
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S38 - S38
  • [50] Dabrafenib in the treatment of metastatic or unresectable melanoma
    Khoja, Leila
    Hogg, David
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 265 - 276
12345